Vaccines Journal

Overview

publication venue for

• The Sm14+GLA-SE Recombinant Vaccine Against Schistosoma mansoni and S. haematobium in Adults and School Children: Phase II Clinical Trials in West Africa..  13. 2025
• The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms..  13. 2025
• Gold Nanoparticle Virus-like Particles Presenting SARS-CoV-2 Spike Protein: Synthesis, Biophysical Properties and Immunogenicity in BALB/c Mice..  12. 2024
• Development of NP-Based Universal Vaccine for Influenza A Viruses..  12. 2024
• Monkeypox Post-COVID-19: Knowledge, Worrying, and Vaccine Adoption in the Arabic General Population..  11. 2023
• Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model..  11. 2023
• An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis..  11. 2023
• Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women..  10. 2022
• Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees..  10. 2022
• Students as Community Vaccinators: Implementation of A Service-Learning COVID-19 Vaccination Program..  10. 2022
• Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease..  10. 2022
• COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated..  10. 2022
• Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study..  10. 2022
• Attitudes and Intentions toward COVID-19 Vaccination among Health Professions Students and Faculty in Qatar..  9. 2021
• A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants..  9. 2021
• Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses..  9. 2021
• Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans..  9. 2021
• Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out..  9. 2021
• Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study..  9. 2021
• Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China..  9. 2021
• Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses..  8. 2020
• Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV..  8. 2020
• Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses..  8. 2020
• Impact of Influenza on Pneumococcal Vaccine Effectiveness during Streptococcus pneumoniae Infection in Aged Murine Lung..  8. 2020
• Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV..  7. 2018
• Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in Mice..  5. 2017
• Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques..  1. 2013
• Beyond Awareness: Hope for a CMV Vaccine! An Introduction to the Conference, "CMV Vaccine Development-How Close Are We?" (27-28 September 2023). 2024
• Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023). 2024
• Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern. 2025
• T Cell Responses during Human Immunodeficiency Virus/Mycobacterium tuberculosis Coinfection. 2024
• Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria. 2024
• From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2. 2024
• Mycobacterium smegmatis, a Promising Vaccine Vector for Preventing TB and Other Diseases: Vaccinomics Insights and Applications. 2023
• Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination. 2022
• B-Cell-Based Immunotherapy: A Promising New Alternative. 2022
• The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. 2021
• Bridging the B Cell Gap: Novel Technologies to Study Antigen-Specific Human B Cell Responses. 2021
• Impact of Maternal Immunity on Congenital Cytomegalovirus Birth Prevalence and Infant Outcomes: A Systematic Review. 2019

Identity

ISO Abbreviation

• Vaccines (Basel)

Linking ISSN

• 2076-393X

International Standard Serial Number (ISSN)

• 2076-393X